Allan M. Fox - 30 May 2025 Form 4 Insider Report for REGENXBIO Inc. (RGNX)

Role
Director
Signature
/s/ Patrick J. Christmas as attorney-in-fact
Issuer symbol
RGNX
Transactions as of
30 May 2025
Net transactions value
$0
Form type
4
Filing time
03 Jun 2025, 16:37:11 UTC
Previous filing
04 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fox Allan M. Director C/O REGENXBIO INC., 9804 MEDICAL CENTER DRIVE, ROCKVILLE /s/ Patrick J. Christmas as attorney-in-fact 03 Jun 2025 0001652936

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGNX Common Stock Award $0 +7,768 +69% $0.000000 19,054 30 May 2025 Direct F1
holding RGNX Common Stock 722,485 30 May 2025 By AMF Family Gift Trust LLC F2
holding RGNX Common Stock 315,000 30 May 2025 By AMF Gift Trust LLC F2
holding RGNX Common Stock 315,000 30 May 2025 By HBF Gift Trust LLC F2
holding RGNX Common Stock 1,529,981 30 May 2025 By Quaker Gray LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGNX Stock Options (Right to Buy) Award $0 +39,815 $0.000000 39,815 30 May 2025 Common Stock 39,815 $8.85 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer.
F2 The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer.